Hydromorphon Stada

Hydromorphone, the active ingredient in Hydromorphon Stada, is an opioid analgesic presented as an oral formulation for oral use. It is prescribed for the management of moderate to severe pain in adult patients when other analgesics are insufficient. The drug acts centrally on the nervous system to provide effective analgesia and sedation, and is classified under the ATC code N02AA02.

GNH USA supplies Hydromorphon Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydromorphone is an opioid analgesic used in the management of pain.

Acute postoperative pain: provides rapid relief after surgical procedures. Cancer‑related pain: helps control severe pain associated with malignant disease. Chronic non‑cancer pain: employed when other analgesics are inadequate for long‑term severe pain.

Hydromorphone may cause a range of adverse reactions, from mild to serious. Patients should be informed of common and less frequent side effects.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness or unsteadiness. - Dry mouth: reduced salivation leading to a parched feeling. - Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing faintness. - Addiction or dependence: potential for misuse and physical dependence. - Adrenal insufficiency: impaired cortisol production. - Seizures: rare occurrence of convulsive episodes.

When prescribing or dispensing Hydromorphone, several safety considerations are essential. - Assess pain level: confirm that opioid therapy is appropriate for the intensity of pain. - Screen for respiratory disorders: avoid use in patients with severe asthma or COPD. - Evaluate hepatic and renal function: dose adjustments may be required in impairment. - Avoid concomitant CNS depressants: limit use with benzodiazepines or alcohol. - Monitor for signs of dependence: watch for cravings, tolerance, or withdrawal. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Hydromorphone can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Other opioids: additive respiratory depression. - Benzodiazepines: increased risk of profound sedation and respiratory compromise. - MAO inhibitors: potential for severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - Anticholinergics: may worsen constipation and urinary retention. - SSRIs or SNRIs: possible serotonin syndrome when combined. - Alcohol: enhances CNS depression and impairs judgment.